PTGX 最新季度财报
公布日期8/5/2026
实际每股收益(美元)2.47
实际营收(美元)213.47M
本页面提供详细的 Protagonist Therapeutics Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Protagonist Therapeutics Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | 2.47/2.08 | 213.47M/203.76M | 18.62% | 4.77% |
| 5/5/2026 | 03/2026 | 0.06/-0.53 | 56.37M/16.27M | 110.91% | 246.39% |
| 2/25/2026 | 12/2025 | -0.69/-0.49 | 7.44M/8.93M | -41.88% | -16.68% |
| 11/6/2025 | 09/2025 | -0.62/-0.64 | 4.71M/3.64M | 3.46% | 29.58% |
| 8/6/2025 | 06/2025 | -0.55/-0.58 | 5.55M/6.81M | 5.35% | -18.51% |
| 5/6/2025 | 03/2025 | -0.19/-0.23 | 28.32M/30.44M | 19.90% | -6.97% |
| 2/21/2025 | 12/2024 | 2.11/0.32 | 170.64M/50.35M | 557.84% | 238.88% |
| 11/7/2024 | 09/2024 | -0.54/-0.61 | 4.67M/2.07M | 11.50% | 125.69% |